55Indexed trials
canonical disease area
Migraine / Headache
Intelligence
Migraine / Headache intelligence: 55 indexed trials, 12 recruiting studies, 46 sponsors across 41 countries.
12Recruiting
46Sponsors
41Countries
Leading sponsors
AbbVie43 recruiting
Eli Lilly and Company30 recruiting
Pfizer30 recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine21 recruiting
HealthPartners Institute20 recruiting
Azienda Sanitaria Locale di Alessandria10 recruiting
Autonomic Technologies, Inc.10 recruiting
Allergan10 recruiting
Dr. Reddy's Laboratories Limited10 recruiting
Dr. Ram Manohar Lohia Hospital11 recruiting
Duke University10 recruiting
Amy Gelfand10 recruiting
Geographic activity
United States28trials
Italy9trials
United Kingdom7trials
Germany7trials
Spain7trials
Canada5trials
France4trials
Poland4trials
Belgium4trials
China3trials
Netherlands3trials
India3trials
Leading interventions
Acupuncture2trials
Atogepant2trials
Transcranial direct current stimulation2trials
Rimegepant2trials
Art-therapy1trials
Anisodine Hydrobromide1trials
Anodal tDCS1trials
Botulinum Toxin Type A 25 IU1trials
Botulinum Toxin Type A 50 IU1trials
Botulinum toxin type A1trials
CEFALY Active1trials
BOLD MRI1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.